메뉴 건너뛰기




Volumn 112, Issue 7, 2008, Pages 2973-2978

Longitudinal analysis of heart and liver iron in thalassemia major

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

EID: 53449102748     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-148767     Document Type: Article
Times cited : (177)

References (40)
  • 1
    • 20844460608 scopus 로고    scopus 로고
    • Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine
    • Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89:1187-1193.
    • (2004) Haematologica , vol.89 , pp. 1187-1193
    • Borgna-Pignatti, C.1    Rugolotto, S.2    De Stefano, P.3
  • 2
    • 29744455463 scopus 로고    scopus 로고
    • Physiology and pathophysiology of iron cardiomyopathy in thalassemia
    • Wood JC, Enriquez C, Ghugre N, et al. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N YAcad Sci. 2005;1054: 386-395.
    • (2005) Ann N YAcad Sci , vol.1054 , pp. 386-395
    • Wood, J.C.1    Enriquez, C.2    Ghugre, N.3
  • 3
    • 3042746877 scopus 로고    scopus 로고
    • Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major
    • Davis BA, O'Sullivan C, Jarritt PH, Porter JB. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood. 2004;104:263-269.
    • (2004) Blood , vol.104 , pp. 263-269
    • Davis, B.A.1    O'Sullivan, C.2    Jarritt, P.H.3    Porter, J.B.4
  • 4
    • 0028086414 scopus 로고
    • Survival in medically treated patients with homozygous beta-thalassemia
    • Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994;331: 574-578.
    • (1994) N Engl J Med , vol.331 , pp. 574-578
    • Olivieri, N.F.1    Nathan, D.G.2    MacMillan, J.H.3
  • 5
    • 0033760134 scopus 로고    scopus 로고
    • Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major
    • Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110: 971-977.
    • (2000) Br J Haematol , vol.110 , pp. 971-977
    • Telfer, P.T.1    Prestcott, E.2    Holden, S.3    Walker, M.4    Hoffbrand, A.V.5    Wonke, B.6
  • 6
    • 0028059813 scopus 로고
    • Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major
    • Brittenham GM, Griffith PM, Nienhuis AW. et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994;331:567-573.
    • (1994) N Engl J Med , vol.331 , pp. 567-573
    • Brittenham, G.M.1    Griffith, P.M.2    Nienhuis, A.W.3
  • 7
    • 0034601375 scopus 로고    scopus 로고
    • Hepatic iron concentration and total body iron stores in thalassemia major
    • Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000; 343:327-331.
    • (2000) N Engl J Med , vol.343 , pp. 327-331
    • Angelucci, E.1    Brittenham, G.M.2    McLaren, C.E.3
  • 8
    • 0031001278 scopus 로고    scopus 로고
    • Iron-chelating therapy and the treatment of thalassemia
    • Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997:89:739-761.
    • (1997) Blood , vol.89 , pp. 739-761
    • Olivieri, N.F.1    Brittenham, G.M.2
  • 9
    • 0036431540 scopus 로고    scopus 로고
    • Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Glin
    • Porter JB. Davis BA. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Glin Haematol. 2002:15:329-368.
    • (2002) Haematol , vol.15 , pp. 329-368
    • Porter, J.B.1    Davis, B.A.2
  • 10
    • 33745892383 scopus 로고    scopus 로고
    • Myocardial iron loading in patients with thalassemia major on deferoxamine chelation
    • Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Gardiovasc Magn Reson. 2006;8:543-547.
    • (2006) J Gardiovasc Magn Reson , vol.8 , pp. 543-547
    • Tanner, M.A.1    Galanello, R.2    Dessi, C.3
  • 11
    • 1442307460 scopus 로고    scopus 로고
    • Myocardial iron loading in transfusion-dependent thalassemia and sicklecell disease
    • Wood JC, Tyszka JM, Ghugre N, Carson S, Nelson MD, Goates TD. Myocardial iron loading in transfusion-dependent thalassemia and sicklecell disease. Blood. 2004;103:1934-1936.
    • (2004) Blood , vol.103 , pp. 1934-1936
    • Wood, J.C.1    Tyszka, J.M.2    Ghugre, N.3    Carson, S.4    Nelson, M.D.5    Goates, T.D.6
  • 12
    • 33846894766 scopus 로고    scopus 로고
    • * assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia
    • * assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica. 2007;92:131-132.
    • (2007) Haematologica , vol.92 , pp. 131-132
    • Aessopos, A.1    Fragodimitri, C.2    Karabatsos, F.3
  • 13
    • 18044399191 scopus 로고    scopus 로고
    • *) magnetic resonance for the early diagnosis of myocardial iron overload
    • *) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171-2179.
    • (2001) Eur Heart J , vol.22 , pp. 2171-2179
    • Anderson, L.J.1    Holden, S.2    Davis, B.3
  • 15
    • 13844256816 scopus 로고    scopus 로고
    • Wang ZJ. Lian L, Chen Q. Zhao H, Asakura T, Cohen AR. 1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model. Radiology. 2005;234:749-755.
    • Wang ZJ. Lian L, Chen Q. Zhao H, Asakura T, Cohen AR. 1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model. Radiology. 2005;234:749-755.
  • 17
    • 31144434350 scopus 로고    scopus 로고
    • Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine
    • Anderson LJ, Westwood MA, Prescott E, Walker JM, Pennell DJ, Wonke B. Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine. Acta Haematol. 2006; 115:106-108.
    • (2006) Acta Haematol , vol.115 , pp. 106-108
    • Anderson, L.J.1    Westwood, M.A.2    Prescott, E.3    Walker, J.M.4    Pennell, D.J.5    Wonke, B.6
  • 19
    • 34247159083 scopus 로고    scopus 로고
    • Magnetic resonance imaging measurement of iron overload
    • Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol. 2007; 14:183-190.
    • (2007) Curr Opin Hematol , vol.14 , pp. 183-190
    • Wood, J.C.1
  • 20
    • 38049113365 scopus 로고    scopus 로고
    • The heart in transfusion dependent homozygous thalassaemia today: Prediction, prevention and management
    • Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous thalassaemia today: prediction, prevention and management. Eur J Haematol. 2008;80:93-106.
    • (2008) Eur J Haematol , vol.80 , pp. 93-106
    • Aessopos, A.1    Berdoukas, V.2    Tsironi, M.3
  • 21
    • 20344381825 scopus 로고    scopus 로고
    • Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration
    • Berdoukas V, Dakin C, Freema A, Fraser I, Aessopos A, Bohane T. Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration. Haematologica. 2005;90:685-686.
    • (2005) Haematologica , vol.90 , pp. 685-686
    • Berdoukas, V.1    Dakin, C.2    Freema, A.3    Fraser, I.4    Aessopos, A.5    Bohane, T.6
  • 23
    • 23744459788 scopus 로고    scopus 로고
    • * mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
    • * mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106:1460-1465.
    • (2005) Blood , vol.106 , pp. 1460-1465
    • Wood, J.C.1    Enriquez, C.2    Ghugre, N.3
  • 25
    • 0027313329 scopus 로고
    • Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells
    • Parkes JG, Hussain RA, Olivieri NF, Templeton DM. Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. J Lab Clin Med. 1993;122:36-47.
    • (1993) J Lab Clin Med , vol.122 , pp. 36-47
    • Parkes, J.G.1    Hussain, R.A.2    Olivieri, N.F.3    Templeton, D.M.4
  • 26
    • 0141461407 scopus 로고    scopus 로고
    • L-type Ca(2+) channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy
    • Oudit GY, Sun H. Trivieri MG, et al. L-type Ca(2+) channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med. 2003;9:1187-1194.
    • (2003) Nat Med , vol.9 , pp. 1187-1194
    • Oudit, G.Y.1    Sun, H.2    Trivieri, M.G.3
  • 27
    • 0028244452 scopus 로고
    • Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron
    • Randell EW, Parkes JG, Olivieri NF, Templeton DM. Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron. J Biol Chem. 1994;269: 16046-16053.
    • (1994) J Biol Chem , vol.269 , pp. 16046-16053
    • Randell, E.W.1    Parkes, J.G.2    Olivieri, N.F.3    Templeton, D.M.4
  • 28
    • 14544271816 scopus 로고    scopus 로고
    • CabantchikZI, Breuer W. Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18:277-287.
    • CabantchikZI, Breuer W. Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18:277-287.
  • 29
    • 33745515012 scopus 로고    scopus 로고
    • Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major
    • Wu KH, Chang JG, Ho YJ, Wu SF, Peng CT Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with beta-thalassemia major. Hemoglobin. 2006;30:251-256.
    • (2006) Hemoglobin , vol.30 , pp. 251-256
    • Wu, K.H.1    Chang, J.G.2    Ho, Y.J.3    Wu, S.F.4    Peng, C.T.5
  • 30
    • 44249100902 scopus 로고    scopus 로고
    • Wood JC, Claster S, Carson S, et al. Vitamin D deficiency, cardiac iron, and cardiac function in thalassemia major. Br J Haematol. 20Q8;141:891-894.
    • Wood JC, Claster S, Carson S, et al. Vitamin D deficiency, cardiac iron, and cardiac function in thalassemia major. Br J Haematol. 20Q8;141:891-894.
  • 32
    • 0038481233 scopus 로고    scopus 로고
    • Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferoxamine: Indication of close relation between myocardial iron content and chelatable iron pool
    • Jensen PD, Jensen FT. Christensen T Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferoxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood. 2003;101:4632-4639.
    • (2003) Blood , vol.101 , pp. 4632-4639
    • Jensen, P.D.1    Jensen, F.T.2    Christensen, T.3    Eiskjaer, H.4    Baandrup, U.5    Nielsen, J.L.6
  • 33
    • 0032992695 scopus 로고    scopus 로고
    • Differential response of nontransferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron
    • Scheiber-Mojdehkar B, Zimmermann I, Dresow B, Goldenberg H. Differential response of nontransferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron. J Hepatol. 1999;31:61-70.
    • (1999) J Hepatol , vol.31 , pp. 61-70
    • Scheiber-Mojdehkar, B.1    Zimmermann, I.2    Dresow, B.3    Goldenberg, H.4
  • 34
    • 0026719970 scopus 로고
    • Deferoxamine-induced iron mobilization and redistribution of myocardial iron in cultured rat heart cells: Studies of the chelatable iron pool by electron microscopy and Mossbauer spectroscopy
    • Shiloh H, lancu TC, Bauminger ER, Link G, Pinson A, Hershko C. Deferoxamine-induced iron mobilization and redistribution of myocardial iron in cultured rat heart cells: studies of the chelatable iron pool by electron microscopy and Mossbauer spectroscopy. J Lab Clin Med. 1992;119: 428-436.
    • (1992) J Lab Clin Med , vol.119 , pp. 428-436
    • Shiloh, H.1    lancu, T.C.2    Bauminger, E.R.3    Link, G.4    Pinson, A.5    Hershko, C.6
  • 35
    • 0030048681 scopus 로고    scopus 로고
    • Results of long-term ironchelating therapy
    • Gabutti V, PigaA. Results of long-term ironchelating therapy. Acta Haematol. 1996;95:26-36.
    • (1996) Acta Haematol , vol.95 , pp. 26-36
    • Gabutti, V.1    PigaA2
  • 36
    • 0034651775 scopus 로고    scopus 로고
    • Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk betathalassemia
    • Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk betathalassemia. Blood. 2000;95:1229-1236.
    • (2000) Blood , vol.95 , pp. 1229-1236
    • Davis, B.A.1    Porter, J.B.2
  • 37
    • 0029978555 scopus 로고    scopus 로고
    • Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
    • Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood. 1996;88:705-713.
    • (1996) Blood , vol.88 , pp. 705-713
    • Porter, J.B.1    Abeysinghe, R.D.2    Marshall, L.3    Hider, R.C.4    Singh, S.5
  • 38
    • 34250360747 scopus 로고    scopus 로고
    • Comparison of twice-daily vs oncedaily deferasirox dosing in a gerbil model of iron cardiomyopathy
    • Otto-Duessel M, Aguilar M, Nick H, Moats R, Wood JC. Comparison of twice-daily vs oncedaily deferasirox dosing in a gerbil model of iron cardiomyopathy. Exp Hematol. 2007;35:1069-1073.
    • (2007) Exp Hematol , vol.35 , pp. 1069-1073
    • Otto-Duessel, M.1    Aguilar, M.2    Nick, H.3    Moats, R.4    Wood, J.C.5
  • 39
    • 0037125595 scopus 로고    scopus 로고
    • Comparison of effects of oral deferiprone and subcutaneous desferoxamine on myocardial iron concentrations and ventricular function in beta-thalassemia
    • Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM. Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferoxamine on myocardial iron concentrations and ventricular function in beta-thalassemia. Lancet. 2002;360:516-520.
    • (2002) Lancet , vol.360 , pp. 516-520
    • Anderson, L.J.1    Wonke, B.2    Prescott, E.3    Holden, S.4    Walker, J.M.5    Pennell, D.J.6
  • 40
    • 33646387405 scopus 로고    scopus 로고
    • Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
    • Pennell DJ. Berdoukas V. Karagiorga M. et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood. 2006;107:3738-3744.
    • (2006) Blood , vol.107 , pp. 3738-3744
    • Pennell, D.J.1    Berdoukas, V.2    Karagiorga, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.